Literature DB >> 32158102

Marburg I Polymorphism (G511E) in Adults with Deep Vein Thrombosis.

Narender Kumar1, Archana Sundaram2, Neetu Rani1, Jasmina Ahluwalia1, Reena Das1, Neelam Varma1, Vikas Suri3, Pankaj Malhotra3.   

Abstract

The Marburg I polymorphism (G511E) in FSAP gene was listed as one of the risk factor for idiopathic DVT among the western population. The frequency of Marburg I polymorphism in India is presently not known. Fifty DVT cases and 50 healthy controls were tested for Marburg I polymorphism using ARMS-PCR technique. The thrombophilic risk factors (Protein C, Protein S, Antithrombin III, Factor V Leiden and antiphospholipid antibodies) were also determined. Marburg I polymorphism (heterozygous) was found in 2 patients (4%) but not in control subjects. These two cases did not have any other thrombophilia markers. Among the thrombophilic markers, heterozygous FVL mutation, PS, PC, AT deficiencies and antiphospholipid antibodies were seen in 10%, 10%, 6%, 6% and 8% of the patients respectively. The controls showed only the presence of antiphospholipid antibodies in 6% of subjects. Marburg I polymorphism among Indians DVT patients was determined for the first time. Its incidence was found in 4% of cases and not in controls. Although not statically significant this may be considered as one of the contributory risk factors for the development of DVT. A larger study is required for the validation of data. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  Deep vein thrombosis; Genetic polymorphism; Marburg I; Thrombophilia

Year:  2019        PMID: 32158102      PMCID: PMC7042457          DOI: 10.1007/s12288-019-01146-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  15 in total

1.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  A protease isolated from human plasma activating factor VII independent of tissue factor.

Authors:  J Römisch; A Feussner; S Vermöhlen; H A Stöhr
Journal:  Blood Coagul Fibrinolysis       Date:  1999-12       Impact factor: 1.276

3.  Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism.

Authors:  G Garewal; R Das; S Varma; Y Chawla; S Prabhakar
Journal:  J Thromb Haemost       Date:  2003-06       Impact factor: 5.824

4.  The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis.

Authors:  Rick van Minkelen; Marieke C H de Visser; Hans L Vos; Rogier M Bertina; Frits R Rosendaal
Journal:  Blood       Date:  2005-06-15       Impact factor: 22.113

5.  Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.

Authors:  Jasmina Ahluwalia; Sreejesh Sreedharanunni; Narender Kumar; Joseph Masih; Sunil Kumar Bose; Neelam Varma; Subhash Varma; Surjit Singh
Journal:  Int J Rheum Dis       Date:  2014-10-08       Impact factor: 2.454

6.  Differences in etiological and clinical manifestations in upper extremity and lower limb deep venous thrombosis patients from India.

Authors:  Navin Pai; Shrimati Shetty; Bipin Kulkarni; Kanjaksha Ghosh
Journal:  Clin Appl Thromb Hemost       Date:  2009-11-10       Impact factor: 2.389

7.  The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).

Authors:  J Roemisch; A Feussner; C Nerlich; H-A Stoehr; T Weimer
Journal:  Blood Coagul Fibrinolysis       Date:  2002-07       Impact factor: 1.276

Review 8.  Epidemiology of factor V Leiden: clinical implications.

Authors:  V De Stefano; P Chiusolo; K Paciaroni; G Leone
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

9.  Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.

Authors:  Abhijit Chougule; Sweta Rajpal; Jasmina Ahluwalia; Sunil Kumar Bose; Joseph Masih; Reena Das; Narender Kumar; Pankaj Malhotra; Vikas Suri
Journal:  Blood Coagul Fibrinolysis       Date:  2016-01       Impact factor: 1.276

10.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Authors:  F R Rosendaal; T Koster; J P Vandenbroucke; P H Reitsma
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.